Back Pain Doctor
Ulnar Tunnel Syndrome
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Ulnar tunnel syndrome occurs when the ulnar nerve is compressed at the wrist as it passes through Guyon’s canal, on the little-finger side of the palm. It is considerably less common than carpal tunnel syndrome, and the pattern of symptoms is different: numbness and tingling in the little and ring fingers, with weakness of grip and pinch rather than thumb-side numbness.
Assessment focuses on confirming the ulnar nerve as the source and establishing where along its course the compression lies. The same nerve can be compressed at the elbow, and a nerve problem in the neck can produce a similar picture, so all three are considered. Examination looks for reduced sensation, loss of muscle bulk in the hand, and specific signs of ulnar nerve weakness. Ultrasound is useful for identifying a ganglion or other structure pressing on the nerve, and nerve conduction studies help localise and grade the compression.
First-line care is aimed at removing whatever is pressing on the nerve (adjusting wrist position, padding, changing handlebar grip or reducing vibration exposure) supported by short-term splinting and simple analgesia. This matters more than it sounds: a meaningful proportion of cases are caused by a cyst or a narrow canal, and these do not resolve with conservative measures. Where a structural cause is found, or where there is weakness, muscle wasting or colour change in the fingers, referral to a hand or orthopaedic surgeon is the appropriate next step. Nerve recovery after decompression is gradual and can take several months to a year.
Common symptoms
- Numbness and tingling in the little and ring fingers
- Weak grip or weak pinch
- Difficulty spreading and closing the fingers
- Clumsiness with typing, instruments or opening jars
Evidence for twelve treatment options in ulnar tunnel syndrome
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Conservative care comes first, and it holds up well. A network meta-analysis of 49 randomised trials and 3,323 patients with carpal tunnel syndrome ranked manual therapy first for both short- and medium-term pain relief, ahead of every injection option including corticosteroid (Chen, Arch Phys Med Rehabil 2025).
Pairing reviewed 2026-09-02.
Where it fits
Load management, splinting where it fits, and addressing what is irritating the nerve come before any injection. Where the nerve is being compressed structurally and function is being lost, surgical review is the right conversation rather than more conservative care.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
No study has tested any needling technique for ulnar nerve compression at the wrist. A search pairing dry needling, trigger point needling and needling with Guyon's canal, the ulnar tunnel and ulnar neuropathy returned nine records, and none was at the wrist. What the search did find is that trigger points can mimic the condition: tender points in the third and fourth dorsal interosseous muscles of the hand referred pain to the ring and little fingers and the ulnar side of the hand and wrist in healthy volunteers (Choi, Pain Physician 2015), and a trigger point in the teres minor at the back of the shoulder has produced numbness in the same fingers (Escobar, Am J Phys Med Rehabil 1988).
Pairing reviewed 2026-10-01.
Where it fits
Relevant mainly to telling the two apart, where a tender hand or shoulder muscle rather than the nerve at the wrist is reproducing the finger symptoms. It does not release the nerve.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Plausible: no studies
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
A search on Guyon's canal and ulnar tunnel syndrome against injection, corticosteroid and hydrodissection returned eleven records and no clinical trial of any injection. What exists is an anatomical study: ultrasound-guided perineural injection was performed in 21 limbs from 11 cadavers and reached the sheath of the ulnar nerve inside the tunnel every time, with no spread into the nerve itself or into the adjacent artery and tendons, and the authors concluded that clinical trials are now needed (Meng, Ultrasound Med Biol 2015). So the injection can be placed accurately at this site. Whether it helps has not been tested.
Pairing reviewed 2026-09-10.
Where it fits
Considered where the diagnosis is confirmed and the compression is not structural. The absence of trial evidence is acknowledged rather than borrowed from the carpal tunnel, which is a different tunnel with a different literature.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. No studies at this site
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
A tested absence. A search pairing Guyon's canal and the ulnar tunnel with shockwave, shock wave, ESWT and extracorporeal returned two records, both false matches on a hospital of the same name, so there is no study of shockwave at this site at all. The carpal tunnel evidence that the class-level verdict rests on is a different nerve in a different tunnel. The one report linking shockwave to this nerve is a harm report from the elbow rather than the wrist: severe partial axonotmesis of the ulnar nerve immediately after shockwave given for medial epicondylitis (Shim, PM R 2015).
Pairing reviewed 2026-09-13.
Where it fits
Considered only for a separate myofascial problem in the forearm or hand, not for the nerve in Guyon's canal. Where a ganglion or another structural cause is compressing the nerve, imaging and a surgical opinion come before any physical therapy.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. No study at this site
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
A tested absence. Searched 17 October 2026: shockwave, shock wave, shock waves, ESWT or pressure wave with Guyon's canal, the ulnar tunnel, hypothenar hammer syndrome or the ulnar side of the wrist returned no records, and a wider search on the ulnar nerve (5 records, all read) found studies only at the elbow. The one trial at that nerve was in cubital tunnel syndrome after burns, a different site (Mohamed, Arch Phys Med Rehabil 2026), and the one harm report linking shockwave to the ulnar nerve is also from the elbow (Shim, PM R 2015). The carpal tunnel evidence is a different nerve in a different tunnel.
Pairing reviewed 2026-10-17.
Where it fits
Plausible for a mild compression on the same reasoning as at the elbow, but untested at the wrist, and patients are told so. Where a ganglion or another structural cause is compressing the nerve, imaging and a surgical opinion come first.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Plausible: no studies
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No clinical study of any kind at this site. A PubMed search on 11 October 2026 pairing platelet-rich plasma with Guyon, ulnar tunnel and handlebar palsy returned no records, and a wider search of 24 records on PRP and the ulnar nerve found nothing about entrapment at the wrist. The nearest was a single report of PRP used inside a collagen tube to bridge a gunshot injury of the nerve, which is nerve reconstruction and not this problem (Foy, Plast Reconstr Surg Glob Open 2023). The randomised trials of PRP around a trapped nerve are at the carpal tunnel, a different nerve in a different tunnel, where an analysis of 12 trials and 749 people ranked it ahead of glucose and cortisone over the short term (Gao, Arch Phys Med Rehabil 2023). At the elbow, PRP injected into the ligament beside this same nerve was followed by scarring around it in three athletes (Thompson, JSES Rev Rep Tech 2020).
Pairing reviewed 2026-10-11.
Where it fits
Not offered for this at present, because nothing has been published at this site in either direction. Ulnar tunnel syndrome often has a specific cause pressing on the nerve, and finding and removing that cause, with rehabilitation, comes first. Weakness or wasting in the hand needs nerve testing and a surgical opinion.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not offered for this
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
A search of dextrose and prolotherapy against ulnar nerve entrapment including Guyon's canal found no study of either at this site. The 13 records returned all concerned the ulnar nerve at the elbow rather than the wrist, and a review of nerve hydrodissection lists the elbow, radial tunnel, saphenous, sciatic and fibular nerves as candidate sites without mentioning Guyon's canal (Colorado, Muscle Nerve 2025).
Pairing reviewed 2026-09-03.
Where it fits
Not offered for this. Ulnar tunnel syndrome at the wrist usually has an identifiable cause (a ganglion, a cyst, or sustained pressure on the heel of the hand) and finding and removing that cause comes first.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
A tested absence rather than an assumption: searches pairing hyaluronic acid, hyaluronate and viscosupplementation with Guyon's canal, the ulnar tunnel and the ulnar nerve returned no trial of hyaluronic acid in this condition, only a volunteer study in which adding it to local anaesthetic did not change how long an ulnar nerve block lasted (Johansson, Acta Anaesthesiol Scand 1985), and reviews that list it as one of several fluids used for nerve hydrodissection (Colorado, Muscle Nerve 2025). There is no joint in the ulnar canal at the wrist to viscosupplement.
Pairing reviewed 2026-09-12.
Where it fits
Not offered for this problem.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Plausible: no studies
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Searched 29 October 2026: Guyon's canal, ulnar tunnel, ulnar canal, ulnar neuropathy at the wrist, handlebar palsy or distal ulnar with dextrose, glucose, hydrodissection, hydrorelease, perineural, prolotherapy, nerve block or ultrasound-guided (24 records), and a randomised-trial and systematic-review pass (3 records, none a treatment study). All were read. There is no treatment study of dextrose, or of any other injection, for ulnar tunnel syndrome at the wrist. The only injection records at Guyon's canal are a cadaver study and a single case of a cortisone nerve block given there for a different condition, complex regional pain syndrome after shingles (Swarnakar, Cureus 2024). Ulnar tunnel syndrome is uncommon and is often caused by a ganglion or another space-occupying lesion, which an injection under the skin cannot address. The dextrose trials at the ulnar nerve are at the elbow, which is the cubital tunnel page.
Pairing reviewed 2026-10-29.
Where it fits
Considered only once imaging has excluded a ganglion or other lesion pressing on the nerve, and only for tender, hypersensitive skin along the nerve's branches in the hand, with the absence of any study at this site stated.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Plausible: no studies
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Searched 29 October 2026: Guyon's canal, ulnar tunnel, ulnar canal, ulnar neuropathy at the wrist, handlebar palsy or distal ulnar with dextrose, glucose, hydrodissection, hydrorelease, perineural, prolotherapy, nerve block or ultrasound-guided (24 records), and a randomised-trial and systematic-review pass (3 records, none a treatment study). All were read. No study has tested hydrodissection for ulnar tunnel syndrome. What exists is groundwork: in 21 cadaver arms, an ultrasound-guided injection aimed at the ulnar nerve inside the ulnar tunnel coated the outside of the nerve in every case without entering it, and the authors say clinical trials are needed (Meng, Ultrasound Med Biol 2015). The hydrodissection trials are at the median nerve in the carpal tunnel. Ulnar tunnel syndrome is often caused by a ganglion or another space-occupying lesion, which needs imaging and usually surgery rather than an injection.
Pairing reviewed 2026-10-29.
Where it fits
Considered only where imaging shows no ganglion or other lesion compressing the nerve and symptoms have not settled with rest from pressure on the heel of the hand (cycling grips, tools) and a splint, with the absence of any study at this site stated.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other elbow, wrist & hand conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Related articles
Shorter articles that answer the questions patients ask most often about this.
Frequently asked questions
How is this different from carpal tunnel syndrome?
What causes it?
Will it settle without surgery?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment